Addex Therapeutics Ltd has appointed Graham Dixon to the newly created position of chief scientific officer and head of research. Dr Dixon was most recently chief scientific officer at Galapagos NV. Prior to this he was CSO at Entomed SA, a developer of natural anticancer and anti-infective agents. Dr Dixon earned his PhD in biochemistry from the University of Swansea and a BSc in applied biology from the University of Bradford in the UK. He will report to the Addex CEO, Bharat Chowrira.
Addex announced the appointment on 3 July 2012.
Copyright 2012 Evernow Publishing Ltd